These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17932971)

  • 1. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 2. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E; Cocco A; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2008 Mar; 14(3):435-6. PubMed ID: 18050300
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn's disease.
    Tada Y; Ishihara S; Ito T; Matsui K; Sonoyama H; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Sato S; Adachi K; Ikeuchi H; Kinoshita Y
    Intern Med; 2013; 52(17):1899-902. PubMed ID: 23994979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.
    Iizuka M; Konno S; Horie Y; Itou H; Shindo K; Watanabe S
    Gut; 2006 May; 55(5):744-5. PubMed ID: 16609139
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for severe gastrointestinal bleeding in Crohn's disease.
    Ando Y; Matsushita M; Kawamata S; Shimatani M; Fujii T; Okazaki K
    Inflamm Bowel Dis; 2009 Mar; 15(3):483-4. PubMed ID: 18668673
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
    Domènech E; Esteve-Comas M; Gomollón F; Hinojosa J; Obrador A; Panés J; Gassull MA;
    Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 12. [Remicade (infliximab) in the treatment of Crohn disease].
    Brazier F; Delcenserie R; Dupas JL
    Presse Med; 2000 Sep; 29(16):1463-4. PubMed ID: 11039091
    [No Abstract]   [Full Text] [Related]  

  • 13. Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.
    Rutgeerts PJ
    Aliment Pharmacol Ther; 1999 Sep; 13 Suppl 4():9-15; discussion 38. PubMed ID: 10597334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussion on predictors of response to infliximab in patients with Crohn's disease.
    Hommes D
    Gastroenterology; 2003 Jun; 124(7):2002-3. PubMed ID: 12812196
    [No Abstract]   [Full Text] [Related]  

  • 15. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y; Debbeche R; Hamzaoui L; Lounissi M; Trabelsi S; Bouzaidi S; Salem M; Abdelmoula L; Najjar T
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
    Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab treatment of massive upper gastrointestinal bleeding in gastroduodenal Crohn's disease.
    Kocaman O; Aygün C; Konduk T; Celebi A; Sentürk O; Hülagü S
    Turk J Gastroenterol; 2008 Sep; 19(3):197-8. PubMed ID: 19115158
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR
    Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.